The Vietnam neurovascular devices market size reached USD 12.00 Million in 2024 and is projected to grow to USD 18.36 Million by 2033, exhibiting a CAGR of 4.84% during 2025-2033. The market growth is driven by an aging population causing increased stroke prevalence, technological advancements enabling minimally invasive neurovascular procedures, and the integration of artificial intelligence improving diagnostic accuracy. Improved healthcare infrastructure and government initiatives to expand stroke care capabilities further support market growth.

Study Assumption Years

• Base Year: 2024

• Historical Year/Period: 2019-2024

• Forecast Year/Period: 2025-2033

Vietnam Neurovascular Devices Market Key Takeaways

• The Vietnam neurovascular devices market size was USD 12.00 Million in 2024.

• The market is expected to grow at a CAGR of 4.84% during 2025-2033.

• The forecast period for market growth is 2025 to 2033.

• Rapidly aging population increases stroke prevalence, driving demand.

• Technological advancements are enabling minimally invasive treatments.

• Artificial intelligence integration enhances diagnostic and treatment capabilities.

• Improved healthcare infrastructure and government initiatives boost market expansion.

Sample Request Link: https://www.imarcgroup.com/vietnam-neurovascular-devices-market/requestsample

Market Growth Factors

The demographic shift in favor of an older population is one of the major factors driving growth of the Vietnamese neurovascular devices market. An increase in the aging population signifies an increased prevalence of hypertension, diabetes, cerebrovascular diseases, stroke, and cerebral aneurysms affecting the population further fueling market growth. As a result, the country now has among the highest rates of stroke in Southeast Asia and thus the demand for specialized neurovascular devices for treating all affected patients, these include stent retrievers, embolic coils, and thrombectomy devices.

Advancements in technology away from open surgical procedures have now brought on the era of endovascular neurovascular surgery where advanced endovascular techniques are the standard of treatment. The next generation of devices could be designed with improved components, materials and configurations to allow clinicians to treat highly complex neurovascular diseases with confidence, which would further reduce procedural complexity, improve procedural reliability and reduce patient recovery time, which in turn would lead to acceptance within health systems and specialist neurovascular centers.

Rapid advances in AI for neurovascular disease management have tremendous implications for Vietnam's healthcare system by automatically and rapidly assessing medical images to improve timely diagnostic and treatment decisions. AI-based platforms can enable rapid clinical decision making, improved patient triage and appropriate referral to specialty care, and enable strategies to overcome the uneven distribution of neurovascular disease care expertise in the country to improve patient outcomes and system efficiencies. Artificial intelligence diagnostic and treatment platforms are likely to ease wide-ranging adoption of advanced neurovascular care across Vietnam.

Market Segmentation

Product Insights:

• Cerebral Embolization and Aneurysm Coiling Devices: Includes embolic coils, flow diverters, and liquid embolic agents used for occluding abnormal blood vessels or aneurysms.

• Cerebral Angioplasty and Stenting Systems: Comprise carotid artery stents and embolic protection devices for treating vascular narrowing.

• Neurothrombectomy Devices: Encompass clot retrieval devices, suction devices, and vascular snares used in removing blood clots from cerebral arteries.

• Support Devices: Include micro catheters and micro guidewires that assist in carrying out precision endovascular procedures.

Application Insights:

• Ischemic Stroke: Devices used primarily to treat blockages causing ischemic stroke.

• Aneurysm: Treatment of cerebral aneurysms with specialized coiling and embolization devices.

• Arteriovenous Malformation and Fistulas (AVM): Devices applicable for treating AVMs and fistulas.

• Stenosis: Treatment of narrowed blood vessels.

• Others: Other neurovascular conditions treated with these devices.

End User Insights:

• Hospitals: Primary users offering comprehensive neurovascular treatment.

• Ambulatory Surgical Centers: Facilities performing minimally invasive procedures.

• Clinics: Smaller healthcare units contributing to patient care.

• Others: Other medical settings utilizing neurovascular devices.

Regional Insights

The report segments Vietnam into Northern, Central, and Southern regions without specifying a dominant region or market shares. Thus, no explicit market share or CAGR data per region is provided to identify a dominant region based on exact statistics.

Key Players

Competitive Landscape

The competitive landscape of the industry has also been examined along with the profiles of the key players.

Customization Note

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us

IMARC Group,

134 N 4th St. Brooklyn, NY 11249, USA,

Email: sales@imarcgroup.com,

Tel No: (D) +91 120 433 0800,

United States: +1-201971-6302